Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.

Reilly C, Mylonakis E, Dewar R, Young B, Nordwall J, Bhagani S, Chia PY, Davis R, Files C, Ginde AA, Hatlen T, Helleberg M, Hayanga A, Jensen TO, Jain MK, Kalomenidis I, Kim K, Lallemand P, Lindegaard B, Menon A, Ognenovska K, Poulakou G, Thorup Røge B, Rogers AJ, Shaw-Saliba K, Sandkovsky U, Trautner BW, Vasudeva SS, Vekstein A, Viens K, Wyncoll J, DuChateau B, Zhang Z, Wu S, Babiker AG, Davey V, Gelijns A, Higgs E, Kan V, Lundgren J, Matthews GV, Lane HC

Open source

DOI: 10.1093/infdis/jiae452
Published: 2025 Mar 17
Container: The Journal of infectious diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiae452,
  title = {Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.},
  author = {Reilly C and Mylonakis E and Dewar R and Young B and Nordwall J and Bhagani S and Chia PY and Davis R and Files C and Ginde AA and Hatlen T and Helleberg M and Hayanga A and Jensen TO and Jain MK and Kalomenidis I and Kim K and Lallemand P and Lindegaard B and Menon A and Ognenovska K and Poulakou G and Thorup Røge B and Rogers AJ and Shaw-Saliba K and Sandkovsky U and Trautner BW and Vasudeva SS and Vekstein A and Viens K and Wyncoll J and DuChateau B and Zhang Z and Wu S and Babiker AG and Davey V and Gelijns A and Higgs E and Kan V and Lundgren J and Matthews GV and Lane HC},
  year = {2025},
  journal = {The Journal of infectious diseases},
  doi = {10.1093/infdis/jiae452},
  url = {https://doi.org/10.1093/infdis/jiae452}
}

RIS

TY  - JOUR
TI  - Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.
AU  - Reilly C
AU  - Mylonakis E
AU  - Dewar R
AU  - Young B
AU  - Nordwall J
AU  - Bhagani S
AU  - Chia PY
AU  - Davis R
AU  - Files C
AU  - Ginde AA
AU  - Hatlen T
AU  - Helleberg M
AU  - Hayanga A
AU  - Jensen TO
AU  - Jain MK
AU  - Kalomenidis I
AU  - Kim K
AU  - Lallemand P
AU  - Lindegaard B
AU  - Menon A
AU  - Ognenovska K
AU  - Poulakou G
AU  - Thorup Røge B
AU  - Rogers AJ
AU  - Shaw-Saliba K
AU  - Sandkovsky U
AU  - Trautner BW
AU  - Vasudeva SS
AU  - Vekstein A
AU  - Viens K
AU  - Wyncoll J
AU  - DuChateau B
AU  - Zhang Z
AU  - Wu S
AU  - Babiker AG
AU  - Davey V
AU  - Gelijns A
AU  - Higgs E
AU  - Kan V
AU  - Lundgren J
AU  - Matthews GV
AU  - Lane HC
PY  - 2025
JO  - The Journal of infectious diseases
DO  - 10.1093/infdis/jiae452
UR  - https://doi.org/10.1093/infdis/jiae452
ER  -

APA

C, R., E, M., R, D., B, Y., J, N., S, B., PY, C., R, D., C, F., AA, G., T, H., M, H., A, H., TO, J., MK, J., I, K., K, K., P, L., B, L., A, M., K, O., G, P., B, T. R., AJ, R., K, S., U, S., BW, T., SS, V., A, V., K, V., J, W., B, D., Z, Z., S, W., AG, B., V, D., A, G., E, H., V, K., J, L., GV, M., & HC, L. (2025). Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019.. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jiae452

Source records

pubmed · retrieved 2026-09-27T08:35:02.917Z